Form D Explorer
Vesalius Longevity Labs (SPV) Inc. · CIK 2056924

Citable research briefCompare issuerPrivate research collection

Vesalius Longevity Labs (SPV) Inc.

CIK 2056924 · Corporation · Inc. BRITISH COLUMBIA, CANADA · VANCOUVER, A1 · Biotechnology
Sign up to follow
Filings
4
Original notices
4
Amendments
0
Activity
Feb 19, 2025
through Mar 19, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMay 13, 2025 · DMar 19, 2026 · DLater minus earlier
Reported offering amount$250,000$6,712,500$6,462,500
Reported amount sold$250,000$6,712,500$6,462,500
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0002060755-25-000010 · Later SEC source: 0002060755-26-000018

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Mar 19, 2026

Reported offering amount
$6,712,500
Reported amount sold
$6,712,500

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Contact info

Log in to look up an email or website for this issuer.

Form D filings (4)